Results · Apr-Jun 2026
Zenotech Laboratories Q1 FY27 results
Sales grew 11% to ₹9.6 crore from ₹8.6 crore in Apr-Jun 2025.
Operating profit fell 110% to −₹0.15 crore, an operating margin of −1.6% (down 18.4 points from a year ago).
Net profit turned into a loss of ₹0.46 crore, from a profit of ₹0.99 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +8%, loss narrows.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 9.6 | 8.6 | +11% |
| Operating profit (EBITDA) | -0.1 | 1.5 | −110% |
| Operating margin | −1.6% | 16.9% | −18.4 pts |
| Net profit | -0.5 | 1.0 | swings to a loss |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.